BioStock: 2021 represents beginning of new era for Fluicell

As we head into the summer, BioStock takes a look at Fluicell’s achievements so far this year. Standing out are the company’s launch of their latest product, Biozone 6, and its dive into the regenerative medicine field through its BioRej Advance programme. BioStock spoke with Fluicell’s CEO Victoire Viannay to get her thoughts on the company’s new direction and what milestones Fluicell has its sights on for the rest of 2021.

Read the interview with Victoire Viannay at biostock.se:

https://www.biostock.se/en/2021-represents-beginning-of-new-era-for-fluicell/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se